Venmax Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE154G01022
  • NSEID:
  • BSEID: 531015
INR
15.90
-0.07 (-0.44%)
BSENSE

Sep 24, 03:30 PM

BSE+NSE Vol: 8.55 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 225982,
    "name": "Venmax Drugs",
    "stock_name": "Venmax Drugs",
    "full_name": "Venmax Drugs & Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/venmax-drugs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "15.90",
    "chg": -0.07,
    "chgp": "-0.44%",
    "dir": -1,
    "prev_price": "15.97",
    "mcapval": "23.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531015,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE154G01022",
    "curr_date": "Sep 24, 03:30 PM",
    "curr_time": "00:57 AM",
    "last_traded_at": "Sep 24, 03:30 PM IST",
    "bse_nse_vol": "8.55 k",
    "exc_status": "Active",
    "traded_date": "Sep 24, 2026",
    "traded_date_str": "2026 09 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/venmax-drugs-225982-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Venmax Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs 12.75 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venmax-drugs-pharmaceuticals-ltd-falls-to-52-week-low-of-rs1275-4196539",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/VenmaxDrugsPhar_priceRelatedfactors_4196539.png",
        "date": "2026-09-17 14:35:06",
        "description": "For the third consecutive session, Venmax Drugs & Pharmaceuticals Ltd has seen its share price decline sharply, culminating in a fresh 52-week low of Rs 12.75 on 17 Sep 2026. This marks a significant 44.28% drop over the past year, considerably underperforming the Sensex, which itself is down 10.02% over the same period."
      },
      {
        "title": "Venmax Drugs & Pharmaceuticals Ltd Falls to 52-Week Low Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venmax-drugs-pharmaceuticals-ltd-falls-to-52-week-low-amidst-continued-downtrend-4179883",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/VenmaxDrugsPhar_priceRelatedfactors_4179883.png",
        "date": "2026-09-02 14:35:10",
        "description": "For the third consecutive session, Venmax Drugs & Pharmaceuticals Ltd has declined, culminating in a fresh 52-week low on 2 Sep 2026, as the stock slipped 7.06%% intraday. This latest drop extends a year-long slide where the share price has halved, contrasting sharply with the broader market's more modest losses."
      },
      {
        "title": "Venmax Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs 14.1 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venmax-drugs-pharmaceuticals-ltd-falls-to-52-week-low-of-rs141-4164188",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/VenmaxDrugsPhar_priceRelatedfactors_4164188.png",
        "date": "2026-08-21 12:05:08",
        "description": "For the second consecutive session, Venmax Drugs & Pharmaceuticals Ltd has seen its share price decline further, hitting a fresh 52-week low of Rs 14.1 on 21 Aug 2026. This drop comes amid a broader market where the Sensex trades marginally higher, underscoring a stark divergence in performance."
      },
      {
        "title": "Venmax Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs 15.56 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venmax-drugs-pharmaceuticals-ltd-falls-to-52-week-low-of-rs1556-4105106",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/VenmaxDrugsPhar_priceRelatedfactors_4105106.png",
        "date": "2026-07-16 10:35:22",
        "description": "A sustained decline has pushed Venmax Drugs & Pharmaceuticals Ltd to a fresh 52-week low of Rs 15.56 on 16 Jul 2026, marking a 34.78% drop over the past year and signalling persistent pressure despite some recent outperformance relative to its sector."
      },
      {
        "title": "Venmax Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs 16 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venmax-drugs-pharmaceuticals-ltd-falls-to-52-week-low-of-rs16-4093806",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/VenmaxDrugsPhar_priceRelatedfactors_4093806.png",
        "date": "2026-07-08 14:35:09",
        "description": ""
      },
      {
        "title": "Venmax Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs 16.31 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venmax-drugs-pharmaceuticals-ltd-falls-to-52-week-low-of-rs1631-4077262",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/VenmaxDrugsPhar_priceRelatedfactors_4077262.png",
        "date": "2026-06-29 13:10:10",
        "description": ""
      }
    ],
    "total": 93,
    "sid": "225982",
    "stock_news_url": "https://www.marketsmojo.com/news/venmax-drugs-pharmaceuticals-225982"
  },
  "announcements": [
    {
      "caption": "NCLT Conveying Shareholder Meeting On October 24 2026 At 12.30 P.M.",
      "datetime": "22-Sep-2026",
      "details": "Venmax Drugs and Pharmaceuticals Limited has informed exchange about the meeting of equity shareholders of the Company pursuant to the order passed by Hon. NCLT Hyderabad bench II in respect of Scheme of Amalgamation of Hatri Pharma Private Limited with Venmax Drugs and Pharmaceuticals Limited.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Scheme of Arrangement",
      "datetime": "08-Sep-2026",
      "details": "Venmax Drugs and Pharmaceuticals Limited has informed the exchange about the update in respect of Scheme of Amalgamation of Hatri Pharma Private Limited (Amalgamating Company) with Venmax Drugs and Pharmaceuticals Limited ( Amalgamated Company).",
      "source": "BSE"
    },
    {
      "caption": "Reg. 34 (1) Annual Report.",
      "datetime": "01-Sep-2026",
      "details": "Submission of Annual Report for the Financial Year 2025-26 Pursuant to Regulation 34 and other relevant provisions of the SEBI (Listing Obligations & Disclosure Requirements) 2015.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

NCLT Conveying Shareholder Meeting On October 24 2026 At 12.30 P.M.

22-Sep-2026 | Source : BSE

Venmax Drugs and Pharmaceuticals Limited has informed exchange about the meeting of equity shareholders of the Company pursuant to the order passed by Hon. NCLT Hyderabad bench II in respect of Scheme of Amalgamation of Hatri Pharma Private Limited with Venmax Drugs and Pharmaceuticals Limited.

Announcement under Regulation 30 (LODR)-Scheme of Arrangement

08-Sep-2026 | Source : BSE

Venmax Drugs and Pharmaceuticals Limited has informed the exchange about the update in respect of Scheme of Amalgamation of Hatri Pharma Private Limited (Amalgamating Company) with Venmax Drugs and Pharmaceuticals Limited ( Amalgamated Company).

Reg. 34 (1) Annual Report.

01-Sep-2026 | Source : BSE

Submission of Annual Report for the Financial Year 2025-26 Pursuant to Regulation 34 and other relevant provisions of the SEBI (Listing Obligations & Disclosure Requirements) 2015.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

Footer loading